Tiziana Life Sciences is a biotechnology business based in the US. Tiziana Life Sciences shares (TLSA) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.96 – a decrease of 2.06% over the previous week. Tiziana Life Sciences employs 9 staff and has a market cap (total outstanding shares value) of 0.00.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $0.96 |
|---|---|
| 52-week range | $0.41 - $1.74 |
| 50-day moving average | $0.96 |
| 200-day moving average | $0.82 |
| Wall St. target price | $3.00 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-0.13 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.9522 from 2024-11-22
| 1 week (2024-11-19) | -2.85% |
|---|---|
| 1 month (2024-10-25) | -3.85% |
| 3 months (2024-08-26) | -22.59% |
| 6 months (2024-05-24) | 17.57% |
| 1 year (2023-11-24) | 73.13% |
|---|---|
| 2 years (2022-11-25) | 51.12% |
| 3 years (2021-11-26) | 1.32 |
| 5 years (2019-11-26) | 1.1497 |
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | -69.58% |
| Return on equity TTM | -181.23% |
| Profit margin | 0% |
| Book value | $0.02 |
| Market Capitalization | $98.9 million |
TTM: trailing 12 months
We're not expecting Tiziana Life Sciences to pay a dividend over the next 12 months.
Tiziana Life Sciences's shares were split on a 2499:1000 basis on 30 July 2020 . So if you had owned 1000 shares the day before before the split, the next day you'd have owned 2499 shares. This wouldn't directly have changed the overall worth of your Tiziana Life Sciences shares – just the quantity. However, indirectly, the new 60% lower share price could have impacted the market appetite for Tiziana Life Sciences shares which in turn could have impacted Tiziana Life Sciences's share price.
Over the last 12 months, Tiziana Life Sciences's shares have ranged in value from as little as $0.41 up to $1.74. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Tiziana Life Sciences's is 0.178. This would suggest that Tiziana Life Sciences's shares are less volatile than average (for this exchange).
Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology in the United States. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases. It also develops Milciclib (TZLS-201), an orally bioavailable small molecule broad spectrum inhibitor of various cyclin-dependent kinases and Src family; and TZLS-501, a fully human mAb targeting the IL-6 receptor for the treatment of inflammatory and oncology indications. Tiziana Life Sciences Ltd was incorporated in 1998 and is headquartered in London, the United Kingdom. .
Some of the best paper trading apps to practice stock trading with fake money include Interactive Brokers, eToro, Charles Schwab and more.
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
These are the best discount brokers of 2024 according to Finder’s comprehensive review.
The best platforms to use for automatic investing include Wealthfront, SoFi, Schwab, Vanguard, Titan, Acorns and more. See our full list here.
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
5 Betterment robo-advisor alternatives to consider when building your portfolio.
What you need to know about investing in the leading indicator for the overall US stock market.
How do you gift stocks to loved ones? Learn the ins and outs of finding the right investments for them.
Check out the best-performing ETFs so far in 2024.
Acorns is a financial service that rounds up your purchases and turns the extra change into investments.